Log in

ASX:LMGLatrobe Magnesium Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/13/2020)
Today's Range
Now: A$0.01
50-Day Range
MA: A$0.01
52-Week Range
Now: A$0.01
Volume20,275 shs
Average VolumeN/A
Market Capitalization$9.08 million
P/E RatioN/A
Dividend YieldN/A
Latrobe Magnesium Limited develops magnesium production plant through combined hydromet extraction process in Australia. The company holds interests in the Latrobe magnesium project located in the Latrobe Valley in Victoria. It intends to harvest magnesium metal from industrial fly ash, which is a waste product of brown coal power generation. Latrobe Magnesium Limited is based in Sydney, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.60 out of 5 stars

Industry, Sector and Symbol

Industry Industrial Metals & Minerals
Phone61 2 8097 0250



Sales & Book Value

Annual Sales$-136,898.00
Book ValueA$0.00 per share



Outstanding Shares1,296,499,968
Market Cap$9.08 million
Next Earnings DateN/A
OptionableNot Optionable

Receive LMG News and Ratings via Email

Sign-up to receive the latest news and ratings for LMG and its competitors with MarketBeat's FREE daily newsletter.

Latrobe Magnesium (ASX:LMG) Frequently Asked Questions

Has Latrobe Magnesium been receiving favorable news coverage?

Press coverage about LMG stock has trended negative this week, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Latrobe Magnesium earned a news impact score of -2.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Latrobe Magnesium.

Who are some of Latrobe Magnesium's key competitors?

Who are Latrobe Magnesium's key executives?

Latrobe Magnesium's management team includes the following people:
  • Mr. David Oliver Paterson, CEO & Director (Age 65)
  • Mr. John Robert Lee, Sec. & Director (Age 72)
  • Mr. David Wandmaker, Gen. Mang. Operations
  • Mr. Jim Siemon, Director of Hazelwood Project & Consultant
  • Mr. D. Stewart, Technical Consultant

What is Latrobe Magnesium's stock symbol?

Latrobe Magnesium trades on the ASX under the ticker symbol "LMG."

What is Latrobe Magnesium's stock price today?

One share of LMG stock can currently be purchased for approximately A$0.01.

How big of a company is Latrobe Magnesium?

Latrobe Magnesium has a market capitalization of $9.08 million and generates $-136,898.00 in revenue each year.

What is Latrobe Magnesium's official website?

The official website for Latrobe Magnesium is www.latrobemagnesium.com.

How can I contact Latrobe Magnesium?

The company can be reached via phone at 61 2 8097 0250.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.